Open the map

Gilead SciencesGILD

Biotech & innovation · NASDAQ · USA

$147.10
Up 0.2% todayClose

Up 19.6% this year and +15.0% since June 26, ahead of the life science sector at +10.7%. Gilead Sciences supplies 3 mapped companies and buys from 1.

Market cap
$180B
This year
+19.6%
1 year
+25.7%
P/E
n/a
P/S
5.9
P/B
15.2

Price vs the life science sector

since Jun 26GILDLife science sector, equal weight
Gilead Sciences (GILD) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. GILD: +15.0% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+5%+10%+15%+20%Jun 26AugSepOct 8GILD +15.0%Sector +10.7% Gilead Sciences (GILD) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. GILD: +15.0% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8GILD+15.0%Sector+10.7%

Supply chain

1 supplier · 3 customers
SUPPLIERS →→ CUSTOMERSIQVIA Holdings (IQV)IQVIQVIA Holdings+0.3%McKesson (MCK)MCKMcKesson+2.2%Cencora (COR)CORCencora+1.3%Cardinal Health (CAH)CAHCardinal Health+2.9%GILDGilead Sciences

Suppliers 1

Customers 3

Open the full chain →

About Gilead Sciences

HIV treatment is the heart of it, Biktarvy above all, with cell therapy in oncology growing alongside.

Theme exposure

BiotechHIVOncology

Products

  • HIV (Biktarvy)
  • Oncology (cell therapy)
  • Liver diseases

Competitors

Risks

  • Dependence on HIV franchise
  • Pipeline execution

Same segment: Biotech & innovation

Innovation-driven biotech companies focused on novel treatment modalities. Segment 3 of 8 in the Medicine, pharma & life science value chain.

AmgenAMGN−1.4%Vertex PharmaceuticalsVRTX−0.5%ModernaMRNA+0.3%RegeneronREGN−0.3%BiogenBIIB−1.7%Alnylam PharmaceuticalsALNY+0.1%United TherapeuticsUTHR−2.2%IncyteINCY−0.6%

Compare GILD

Side by side with the largest companies in the same segment.

GILD vs AMGNGILD vs VRTXGILD vs MRNAGILD vs REGNGILD vs BIIBGILD vs ALNY

See where Gilead Sciences sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →